Serum Copeptin Levels Predict Clinical Outcomes After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the...
Saved in:
| Published in | Annals of laboratory medicine Vol. 38; no. 6; pp. 538 - 544 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
The Korean Society for Laboratory Medicine
01.11.2018
대한진단검사의학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2234-3806 2234-3814 2234-3814 |
| DOI | 10.3343/alm.2018.38.6.538 |
Cover
| Abstract | Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the prognostic role of serum copeptin levels immediately after successful PCI as a prognostic marker for major adverse cardiac events (MACE; comprising death, repeat PCI, recurrent MI, or coronary artery bypass grafting) in patients with AMI.
A retrospective study was performed in 149 patients with AMI who successfully received PCI. Serum copeptin levels were analyzed in blood samples collected immediately after PCI. The association between copeptin levels and MACE during the follow-up period was evaluated.
MACE occurred in 34 (22.8%) patients during a median follow-up of 30.1 months. MACE patients had higher copeptin levels than non-MACE patients did. Multiple logistic regression analysis showed that the increase in serum copeptin levels was associated with increased MACE incidence (odds ratio=1.6, P=0.005).
A high level of serum copeptin measured immediately after PCI was associated with MACE in patients with AMI during long-term follow-up. Serum copeptin levels can serve as a prognostic marker in patients with AMI after successful PCI. |
|---|---|
| AbstractList | Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the prognostic role of serum copeptin levels immediately after successful PCI as a prognostic marker for major adverse cardiac events (MACE; comprising death, repeat PCI, recurrent MI, or coronary artery bypass grafting) in patients with AMI.
A retrospective study was performed in 149 patients with AMI who successfully received PCI. Serum copeptin levels were analyzed in blood samples collected immediately after PCI. The association between copeptin levels and MACE during the follow-up period was evaluated.
MACE occurred in 34 (22.8%) patients during a median follow-up of 30.1 months. MACE patients had higher copeptin levels than non-MACE patients did. Multiple logistic regression analysis showed that the increase in serum copeptin levels was associated with increased MACE incidence (odds ratio=1.6, P=0.005).
A high level of serum copeptin measured immediately after PCI was associated with MACE in patients with AMI during long-term follow-up. Serum copeptin levels can serve as a prognostic marker in patients with AMI after successful PCI. Background: Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the prognostic role of serum copeptin levels immediately after successful PCI as a prognostic marker for major adverse cardiac events (MACE; comprising death, repeat PCI, recurrent MI, or coronary artery bypass grafting) in patients with AMI. Methods: A retrospective study was performed in 149 patients with AMI who successfully received PCI. Serum copeptin levels were analyzed in blood samples collected immediately after PCI. The association between copeptin levels and MACE during the follow-up period was evaluated. Results: MACE occurred in 34 (22.8%) patients during a median follow-up of 30.1 months. MACE patients had higher copeptin levels than non-MACE patients did. Multiple logistic regression analysis showed that the increase in serum copeptin levels was associated with increased MACE incidence (odds ratio=1.6, P=0.005). Conclusions: A high level of serum copeptin measured immediately after PCI was associated with MACE in patients with AMI during long-term follow-up. Serum copeptin levels can serve as a prognostic marker in patients with AMI after successful PCI. KCI Citation Count: 2 Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the prognostic role of serum copeptin levels immediately after successful PCI as a prognostic marker for major adverse cardiac events (MACE; comprising death, repeat PCI, recurrent MI, or coronary artery bypass grafting) in patients with AMI.BACKGROUNDSerum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However, the prognostic value of copeptin after percutaneous coronary intervention (PCI) for clinical outcomes remains uncertain. We investigated the prognostic role of serum copeptin levels immediately after successful PCI as a prognostic marker for major adverse cardiac events (MACE; comprising death, repeat PCI, recurrent MI, or coronary artery bypass grafting) in patients with AMI.A retrospective study was performed in 149 patients with AMI who successfully received PCI. Serum copeptin levels were analyzed in blood samples collected immediately after PCI. The association between copeptin levels and MACE during the follow-up period was evaluated.METHODSA retrospective study was performed in 149 patients with AMI who successfully received PCI. Serum copeptin levels were analyzed in blood samples collected immediately after PCI. The association between copeptin levels and MACE during the follow-up period was evaluated.MACE occurred in 34 (22.8%) patients during a median follow-up of 30.1 months. MACE patients had higher copeptin levels than non-MACE patients did. Multiple logistic regression analysis showed that the increase in serum copeptin levels was associated with increased MACE incidence (odds ratio=1.6, P=0.005).RESULTSMACE occurred in 34 (22.8%) patients during a median follow-up of 30.1 months. MACE patients had higher copeptin levels than non-MACE patients did. Multiple logistic regression analysis showed that the increase in serum copeptin levels was associated with increased MACE incidence (odds ratio=1.6, P=0.005).A high level of serum copeptin measured immediately after PCI was associated with MACE in patients with AMI during long-term follow-up. Serum copeptin levels can serve as a prognostic marker in patients with AMI after successful PCI.CONCLUSIONSA high level of serum copeptin measured immediately after PCI was associated with MACE in patients with AMI during long-term follow-up. Serum copeptin levels can serve as a prognostic marker in patients with AMI after successful PCI. |
| Author | Hong, Young Joon Jeong, Myung Ho Kim, Min Chul Sim, Doo Sun Ahn, Youngkeun Kim, Ju Han Shin, Myung-Geun Choi, Hyun-Jung Kim, Soo-Hyun |
| AuthorAffiliation | 2 Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea 1 Departments of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea |
| AuthorAffiliation_xml | – name: 1 Departments of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea – name: 2 Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea |
| Author_xml | – sequence: 1 givenname: Hyun-Jung surname: Choi fullname: Choi, Hyun-Jung organization: Departments of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea – sequence: 2 givenname: Min Chul surname: Kim fullname: Kim, Min Chul organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea – sequence: 3 givenname: Doo Sun surname: Sim fullname: Sim, Doo Sun organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea – sequence: 4 givenname: Young Joon surname: Hong fullname: Hong, Young Joon organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea – sequence: 5 givenname: Ju Han surname: Kim fullname: Kim, Ju Han organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea – sequence: 6 givenname: Myung Ho surname: Jeong fullname: Jeong, Myung Ho organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea – sequence: 7 givenname: Soo-Hyun surname: Kim fullname: Kim, Soo-Hyun organization: Departments of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea – sequence: 8 givenname: Myung-Geun orcidid: 0000-0002-0372-9185 surname: Shin fullname: Shin, Myung-Geun organization: Departments of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea – sequence: 9 givenname: Youngkeun orcidid: 0000-0003-2022-9366 surname: Ahn fullname: Ahn, Youngkeun organization: Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30027697$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002401604$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1kk1vEzEQhi1UREvoD-CCfIRDgr2z691ckKKIj0hBjWgRR8vrnaWmXjvY3kj9F_xkvE1bARK-jD_e9xnNeJ6TE-cdEvKSswVACW-VHRYF480CmoVYVNA8IWdFAeUcGl6ePO6ZOCXnMf5geQnGiyV7Rk6BsaIWy_qM_LrEMA507fe4T8bRLR7QRroL2Bmd6NoaZ7Sy9GJM2g8Y6apPGOjlqDXG2I-W7jDoMSmHfoyZE7xT4ZZuXJYd0CXjHc3cnUomnyL9ZtI1XWUH0s-3XqvQmYzfuF4FPYlfkKe9shHP7-OMfP3w_mr9ab69-LhZr7ZzXQKkOS-rshcdZ13LdcVb0bSa1-WStUVV1V2lGbat0K0oVZmvocO-RFUAiEY0Xc9hRt4cuS708kYb6ZW5i9-9vAly9eVqI6Gum9yprH131O7HdsBO50KCsnIfzJBrvXP-_eLMdeYcpGCVgOWU7PU9IPifI8YkBxM1WntsmyxYDQB8-tcZefVnrsckD1-WBfVRoIOPMWAvtUlqal1ObazkTE4cmedDTvMhoZFC5vnITv6P8wH-f89vTafBOg |
| CitedBy_id | crossref_primary_10_1007_s12265_020_10055_y crossref_primary_10_1016_j_ajem_2021_05_052 crossref_primary_10_1007_s12265_024_10584_w crossref_primary_10_3390_children9030443 crossref_primary_10_1210_jc_2019_01049 crossref_primary_10_1177_1535370220943124 crossref_primary_10_1007_s11845_023_03276_y crossref_primary_10_1016_j_clinbiochem_2020_10_008 crossref_primary_10_3389_fcvm_2022_901990 |
| Cites_doi | 10.1002/ccd.24542 10.1016/j.cardfail.2008.07.231 10.1373/clinchem.2015.240580 10.1056/NEJMoa1002358 10.1016/j.jacc.2012.08.001 10.1056/NEJMcp0909392 10.1097/CCM.0000000000000716 10.1093/eurheartj/ehx393 10.1016/j.jacc.2009.01.076 10.1038/295299a0 10.1016/0735-1097(92)90631-V 10.1136/heartjnl-2015-308183 10.1161/CIRCULATIONAHA.106.685313 10.1373/clinchem.2005.060038 10.1016/j.ijcard.2011.12.105 10.1016/j.tem.2007.11.001 10.1002/ana.21783 10.1016/j.amjcard.2011.06.024 10.1016/j.jacc.2011.11.024 10.1212/WNL.0b013e31820b75e6 10.1093/eurheartj/ehp098 10.1161/hc0502.104278 10.1161/CIRCULATIONAHA.106.685503 10.1016/S0002-9149(99)00149-6 10.1016/S0735-1097(03)01044-1 10.1515/cclm-2014-0379 10.1016/j.jacc.2015.02.032 10.1111/jne.12052 |
| ContentType | Journal Article |
| Copyright | The Korean Society for Laboratory Medicine. The Korean Society for Laboratory Medicine 2018 The Korean Society for Laboratory Medicine |
| Copyright_xml | – notice: The Korean Society for Laboratory Medicine. – notice: The Korean Society for Laboratory Medicine 2018 The Korean Society for Laboratory Medicine |
| DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.3343/alm.2018.38.6.538 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2234-3814 |
| EndPage | 544 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_3778002 PMC6056391 30027697 10_3343_alm_2018_38_6_538 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; grantid: HI15C0498 – fundername: ; grantid: CRI14035-1 – fundername: ; grantid: 2015M3A9B4051063; 2015M3A9B4066496; 2015R1D1A1A01057910; 2016R1D1A1A09917796 |
| GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU ECGQY EF. EMOBN GX1 HYE KQ8 M48 PGMZT RPM M~E NPM OK1 7X8 5PM OZF |
| ID | FETCH-LOGICAL-c433t-1454f6d10db1c51b68bc17490b2557d5c0ebb6cb64a47493def4ea2336868df13 |
| IEDL.DBID | M48 |
| ISSN | 2234-3806 2234-3814 |
| IngestDate | Tue Nov 21 21:44:51 EST 2023 Thu Aug 21 18:36:28 EDT 2025 Fri Jul 11 02:52:20 EDT 2025 Wed Feb 19 02:43:27 EST 2025 Thu Apr 24 23:07:44 EDT 2025 Tue Jul 01 03:11:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Myocardial infarction Major adverse cardiac events Percutaneous coronary intervention Prognosis Copeptin |
| Language | English |
| License | The Korean Society for Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c433t-1454f6d10db1c51b68bc17490b2557d5c0ebb6cb64a47493def4ea2336868df13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
| ORCID | 0000-0003-2022-9366 0000-0002-0372-9185 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2018.38.6.538 |
| PMID | 30027697 |
| PQID | 2073331334 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_3778002 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6056391 proquest_miscellaneous_2073331334 pubmed_primary_30027697 crossref_citationtrail_10_3343_alm_2018_38_6_538 crossref_primary_10_3343_alm_2018_38_6_538 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-11-01 |
| PublicationDateYYYYMMDD | 2018-11-01 |
| PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Annals of laboratory medicine |
| PublicationTitleAlternate | Ann Lab Med |
| PublicationYear | 2018 |
| Publisher | The Korean Society for Laboratory Medicine 대한진단검사의학회 |
| Publisher_xml | – name: The Korean Society for Laboratory Medicine – name: 대한진단검사의학회 |
| References | Tu (10.3343/alm.2018.38.6.538_ref11) 2013; 25 Land (10.3343/alm.2018.38.6.538_ref8) 1982; 295 Zellweger (10.3343/alm.2018.38.6.538_ref2) 2012; 59 Morgenthaler (10.3343/alm.2018.38.6.538_ref9) 2006; 52 Khan (10.3343/alm.2018.38.6.538_ref22) 2007; 115 Kelly (10.3343/alm.2018.38.6.538_ref23) 2008; 14 Ibáñez (10.3343/alm.2018.38.6.538_ref28) 2015; 65 Morgenthaler (10.3343/alm.2018.38.6.538_ref7) 2008; 19 Tasevska (10.3343/alm.2018.38.6.538_ref10) 2016; 102 Manginas (10.3343/alm.2018.38.6.538_ref16) 1999; 83 McMurray (10.3343/alm.2018.38.6.538_ref29) 2010; 362 Ioannidis (10.3343/alm.2018.38.6.538_ref4) 2003; 42 Katan (10.3343/alm.2018.38.6.538_ref25) 2009; 66 Bolignano (10.3343/alm.2018.38.6.538_ref6) 2014; 52 Ibanez (10.3343/alm.2018.38.6.538_ref15) 2018; 39 Stone (10.3343/alm.2018.38.6.538_ref1) 2011; 364 Reichlin (10.3343/alm.2018.38.6.538_ref19) 2009; 54 Jarai (10.3343/alm.2018.38.6.538_ref26) 2011; 108 Slagman (10.3343/alm.2018.38.6.538_ref20) 2015; 61 CLSI (10.3343/alm.2018.38.6.538_ref13) 2010 Jang (10.3343/alm.2018.38.6.538_ref5) 2013; 81 von Haehling (10.3343/alm.2018.38.6.538_ref21) 2012; 162 Katan (10.3343/alm.2018.38.6.538_ref24) 2011; 76 Voors (10.3343/alm.2018.38.6.538_ref12) 2009; 30 Myler (10.3343/alm.2018.38.6.538_ref17) 1992; 19 Akkerhuis (10.3343/alm.2018.38.6.538_ref3) 2002; 105 Thygesen (10.3343/alm.2018.38.6.538_ref14) 2012; 60 Cutlip (10.3343/alm.2018.38.6.538_ref18) 2007; 115 Geri (10.3343/alm.2018.38.6.538_ref27) 2015; 43 |
| References_xml | – volume: 81 start-page: 959 year: 2013 ident: 10.3343/alm.2018.38.6.538_ref5 publication-title: Catheter Cardiovasc Interv doi: 10.1002/ccd.24542 – volume: 14 start-page: 739 year: 2008 ident: 10.3343/alm.2018.38.6.538_ref23 publication-title: J Card Fail doi: 10.1016/j.cardfail.2008.07.231 – volume: 61 start-page: 1273 year: 2015 ident: 10.3343/alm.2018.38.6.538_ref20 publication-title: Clin Chem doi: 10.1373/clinchem.2015.240580 – volume: 364 start-page: 226 year: 2011 ident: 10.3343/alm.2018.38.6.538_ref1 publication-title: N Engl J Med doi: 10.1056/NEJMoa1002358 – volume: 60 start-page: 1581 year: 2012 ident: 10.3343/alm.2018.38.6.538_ref14 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.08.001 – volume: 362 start-page: 228 year: 2010 ident: 10.3343/alm.2018.38.6.538_ref29 publication-title: N Engl J Med doi: 10.1056/NEJMcp0909392 – volume: 43 start-page: 422 year: 2015 ident: 10.3343/alm.2018.38.6.538_ref27 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000000716 – volume: 39 start-page: 119 year: 2018 ident: 10.3343/alm.2018.38.6.538_ref15 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx393 – volume-title: Procedures for the Handling and Processing of Blood Specimen for Common Laboratory Tests year: 2010 ident: 10.3343/alm.2018.38.6.538_ref13 – volume: 54 start-page: 60 year: 2009 ident: 10.3343/alm.2018.38.6.538_ref19 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.01.076 – volume: 295 start-page: 299 year: 1982 ident: 10.3343/alm.2018.38.6.538_ref8 publication-title: Nature doi: 10.1038/295299a0 – volume: 19 start-page: 1641 year: 1992 ident: 10.3343/alm.2018.38.6.538_ref17 publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(92)90631-V – volume: 102 start-page: 127 year: 2016 ident: 10.3343/alm.2018.38.6.538_ref10 publication-title: Heart doi: 10.1136/heartjnl-2015-308183 – volume: 115 start-page: 2344 year: 2007 ident: 10.3343/alm.2018.38.6.538_ref18 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.685313 – volume: 52 start-page: 112 year: 2006 ident: 10.3343/alm.2018.38.6.538_ref9 publication-title: Clin Chem doi: 10.1373/clinchem.2005.060038 – volume: 162 start-page: 27 year: 2012 ident: 10.3343/alm.2018.38.6.538_ref21 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2011.12.105 – volume: 19 start-page: 43 year: 2008 ident: 10.3343/alm.2018.38.6.538_ref7 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2007.11.001 – volume: 66 start-page: 799 year: 2009 ident: 10.3343/alm.2018.38.6.538_ref25 publication-title: Ann Neurol doi: 10.1002/ana.21783 – volume: 108 start-page: 1188 year: 2011 ident: 10.3343/alm.2018.38.6.538_ref26 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2011.06.024 – volume: 59 start-page: 793 year: 2012 ident: 10.3343/alm.2018.38.6.538_ref2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.11.024 – volume: 76 start-page: 563 year: 2011 ident: 10.3343/alm.2018.38.6.538_ref24 publication-title: Neurology doi: 10.1212/WNL.0b013e31820b75e6 – volume: 30 start-page: 1187 year: 2009 ident: 10.3343/alm.2018.38.6.538_ref12 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehp098 – volume: 105 start-page: 554 year: 2002 ident: 10.3343/alm.2018.38.6.538_ref3 publication-title: Circulation doi: 10.1161/hc0502.104278 – volume: 115 start-page: 2103 year: 2007 ident: 10.3343/alm.2018.38.6.538_ref22 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.685503 – volume: 83 start-page: 1562 year: 1999 ident: 10.3343/alm.2018.38.6.538_ref16 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)00149-6 – volume: 42 start-page: 1406 year: 2003 ident: 10.3343/alm.2018.38.6.538_ref4 publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)01044-1 – volume: 52 start-page: 1447 year: 2014 ident: 10.3343/alm.2018.38.6.538_ref6 publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2014-0379 – volume: 65 start-page: 1454 year: 2015 ident: 10.3343/alm.2018.38.6.538_ref28 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.02.032 – volume: 25 start-page: 771 year: 2013 ident: 10.3343/alm.2018.38.6.538_ref11 publication-title: J Neuroendocrinol doi: 10.1111/jne.12052 |
| SSID | ssj0000601290 |
| Score | 2.2073367 |
| Snippet | Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction (AMI). However,... Background: Serum copeptin has been demonstrated to be useful in early risk stratification and prognostication of patients with acute myocardial infarction... |
| SourceID | nrf pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 538 |
| SubjectTerms | Original 병리학 |
| Title | Serum Copeptin Levels Predict Clinical Outcomes After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30027697 https://www.proquest.com/docview/2073331334 https://pubmed.ncbi.nlm.nih.gov/PMC6056391 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002401604 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Annals of Laboratory Medicine, 2018, 38(6), , pp.538-544 |
| journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: DYU dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.cabidigitallibrary.org/product/zd providerName: CAB International – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: KQ8 dateStart: 20120101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: DIK dateStart: 20120101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: GX1 dateStart: 20120101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: 5-W dateStart: 20120101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2234-3814 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2234-3814 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0000601290 issn: 2234-3806 databaseCode: M48 dateStart: 20120101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELa2i4S4IN6Ex8ogTkgpcce1nQNC1YplF1GoBBW9WXFss9WGFPKQ2H_BT2bcpNUWVYhTpGTsxJ4Zz3zxeIaQF5kcKeOSLDY24TH3wOI0Uz7OEnA89zKV6zKd04_idM7fL8aLA7Ipb9VPYL0X2oV6UvOqGP76efkGFf51QJzA4VVWhCPlTA1BDcUQNXhArqFhGgUhn_befrcwb_66oE3kMahEdPuc-3vZsVSDsvL7nNC_YymvGKeTW-Rm71XSSScGt8mBK--Q69N-3_wu-Y1LQvudHuPYcIko6YcQKlTTWRUoGtonBy3op7ZBCXQ1nYTS4fRzuy6n6NuCzlyVt-hIulVbYz_VKhzjpWdXIiYp9jvrsrTW9OuyOacTbOHo9BLNZRDDAsk96lUgvkfmJ2-_HJ_GfS2GOOcATcz4mHthWWINy8fMCGVyBDNpYhCTSDvOE2eMyI3gGcfbYJ3nLhsBCCWU9Qzuk8NyVbqHhMLIsMQo7w1PuYUslanlwA0w76wCG5FkM-867xOVh3oZhUbAElilkVU6sEqD0kIjqyLyctvkR5el41_Ez5GZ-iJf6pBbO1y_rfRFpRFBnGmQMvjQEXm24bVGhQu7KN0UY18SABDa84g86Hi_fScElC9SGRG5IxVbgvDC3Sfl8nyd1BthJTqL7NH_fNxjciOMqAsgekIOm6p1T9E3aswRGbxbsKO13P8ByloPJQ |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Copeptin+Levels+Predict+Clinical+Outcomes+After+Successful+Percutaneous+Coronary+Intervention+in+Patients+With+Acute+Myocardial+Infarction&rft.jtitle=Annals+of+laboratory+medicine&rft.au=%EC%B5%9C%ED%98%84%EC%A0%95&rft.au=%EA%B9%80%EB%AF%BC%EC%B2%A0&rft.au=%EC%8B%AC%EB%91%90%EC%84%A0&rft.au=%ED%99%8D%EC%98%81%EC%A4%80&rft.date=2018-11-01&rft.pub=%EB%8C%80%ED%95%9C%EC%A7%84%EB%8B%A8%EA%B2%80%EC%82%AC%EC%9D%98%ED%95%99%ED%9A%8C&rft.issn=2234-3806&rft.eissn=2234-3814&rft.spage=538&rft.epage=544&rft_id=info:doi/10.3343%2Falm.2018.38.6.538&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_3778002 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon |